Cathie Wooden’s Ark Make investments Masses Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce – ARK Genomic Revolution ETF (BATS:ARKG), Adaptive Biotechnologies (NASDAQ:ADPT)

Cathie Wooden-led Ark Make investments made important trades in 5 main firms on Friday: Recursion Prescription drugs Inc. RXRX, Illumina Inc. ILMN, Intellia Therapeutics Inc. NTLA, Cloudflare Inc. NET, and Adaptive Biotechnologies Corp. ADPT.

The RXRX Commerce

Ark Make investments’s ARK Innovation ETF ARKK bought a considerable 264,596 shares of Recursion Prescription drugs.

The worth of this commerce, calculated from the closing value of $6.88, is roughly $1.82 million. This transfer comes regardless of RXRX’s inventory closing at a 5.23% lower on Friday.

The ILMN Commerce

Ark Make investments’s Genomic Revolution ETF ARKG and ARK Innovation ETF each purchased shares of Illumina Inc.

ARKG acquired 4038 shares, whereas ARKK bought 11425 shares. The mixed worth of those trades, calculated from the closing value of $136.69, is roughly $1.97 million.

This transfer was made regardless of Illumina’s inventory closing at a 2.14% lower on Friday.

See Additionally: Bitcoin Supercycle Incoming, Says Economist, However There’s A Catch

The NTLA Commerce

Ark Make investments’s Genomic Revolution ETF and ARK Innovation ETF each purchased shares of Intellia Therapeutics.

ARKG acquired 41503 shares, whereas ARKK bought 124799 shares.

The mixed worth of those trades, calculated from the closing value of $10.2, is roughly $1.46 million. This transfer was made regardless of NTLA’s inventory closing at a 15.14% lower on Friday.

Intellia Therapeutics introduced a 27% workforce discount on Friday to chop prices.

The NET Commerce

Ark Make investments’s Subsequent Era Web ETF (ARKW) offered 7840 shares of Cloudflare.

The worth of this commerce, calculated from the closing value of $112.62, is roughly $882,608. This transfer was made regardless of NET’s inventory closing at a 2.66% lower on Friday.

The ADPT Commerce

Ark Make investments’s Genomic Revolution ETF offered 130,790 shares of Adaptive Biotechnologies.

The worth of this commerce, calculated from the closing value of $6.5, is roughly $850,135. This transfer was made regardless of ADPT’s inventory closing at a 2.84% lower on Friday.

Learn Subsequent:

Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and printed by Benzinga editors.

Photograph courtesy: Ark Make investments